1. Clinical Overview
A fixed-dose combination (FDC) syrup used as a mucolytic, expectorant, and bronchodilator for the symptomatic management of productive cough and bronchospasm associated with acute and chronic respiratory conditions. It is a rational combination where Ambroxol thins and loosens mucus, Guaifenesin increases respiratory tract fluid output, and Terbutaline relaxes bronchial smooth muscle.
| Onset | Duration | Bioavailability |
|---|---|---|
| Terbutaline: 5-30 minutes (bronchodilation); Ambroxol & Guaifenesin: 30-60 minutes (mucolytic/expectorant effect). | Terbutaline: 4-8 hours; Ambroxol: 8-12 hours; Guaifenesin: 4-6 hours. | Ambroxol: ~70-80%; Guaifenesin: Highly variable, ~45-60%; Terbutaline (Oral): ~33-50%. |
2. Mechanism of Action
The combination works via three distinct but complementary mechanisms: 1) Ambroxol disrupts acid mucopolysaccharide fibers in sputum, reduces viscosity, and stimulates surfactant production. 2) Guaifenesin enhances the output of respiratory tract fluid by reducing surface tension and adhesiveness, facilitating ciliary clearance. 3) Terbutaline stimulates intracellular adenyl cyclase, increasing cyclic AMP, leading to relaxation of bronchial smooth muscle and inhibition of mast cell mediator release.
3. Indications & Uses
- Symptomatic treatment of acute and chronic bronchopulmonary diseases associated with viscid mucus and bronchospasm (e.g., Acute Bronchitis, COPD exacerbations)
- Management of productive cough with wheezing or chest tightness
4. Dosage & Administration
Adult Dosage: 10 ml (2 teaspoonfuls) three times a day. Maximum: 30 ml/day.
Administration: Should be taken orally after meals with a full glass of water to improve expectorant effect. Use the measuring cup/spoon provided. Do not lie down immediately after administration. Shake the bottle well before use.
5. Side Effects
Common side effects may include:
- Nausea
- Vomiting
- Diarrhea
- Gastric irritation
- Mild tremor (especially hands)
- Headache
- Dizziness
- Palpitations
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Beta-blockers (e.g., Propranolol) | Antagonizes bronchodilator effect of Terbutaline; may cause severe bronchospasm in asthmatics. | Major |
| Diuretics (e.g., Furosemide, Thiazides) | Terbutaline-induced hypokalemia can be potentiated, increasing risk of arrhythmias. | Major |
| Monoamine Oxidase Inhibitors (MAOIs) & Tricyclic Antidepressants (TCAs) | Potentiates the cardiovascular effects (hypertension, tachycardia) of Terbutaline. | Major |
| Other Sympathomimetics (e.g., Decongestants, Theophylline) | Additive cardiovascular and CNS stimulant effects, increased risk of side effects. | Moderate |
| Digoxin | Hypokalemia from Terbutaline may increase risk of digoxin toxicity. | Moderate |
| CNS Depressants (Alcohol, Benzodiazepines) | Guaifenesin may have additive sedative effects (though minimal). | Minor |
7. Patient Counselling
- DO take after meals with plenty of water.
- DO complete the prescribed course; do not stop abruptly if taking for chronic condition.
- DO inform your doctor if you have heart, thyroid, or diabetic conditions.
- DO use a spacer if also using inhaled corticosteroids.
- DONT exceed the prescribed dose.
- DONT take with other cough/cold medicines without consulting a doctor.
- DONT use for dry, irritating cough.
8. Toxicology & Storage
Overdose: Symptoms are primarily due to Terbutaline: Severe tachycardia, arrhythmias, hypotension or hypertension, tremors, nervousness, metabolic acidosis, hypokalemia. Nausea, vomiting from other components. Seizures reported with massive Guaifenesin overdose.
Storage: Store at room temperature (15-30°C), protected from light and moisture. Keep the bottle tightly closed. Keep out of reach of children. Do not use after the expiry date. Do not freeze.